Mesenchymal stromal cell therapy for COVID-19 acute respiratory distress syndrome: a double-blind randomised controlled trial

Bone Marrow Transplantation, Published online: 26 February 2024; doi:10.1038/s41409-024-02230-5Mesenchymal stromal cell therapy for COVID-19 acute respiratory distress syndrome: a double-blind randomised controlled trial
Source: Bone Marrow Transplantation - Category: Hematology Authors: Source Type: research